APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oxycodone Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchOxycodone Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oxycodone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Oxycodone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxycodone include Teva Pharmaceuticals, Sun Pharmaceutical (Chattem Chemicals), Sanofi, Johnson & Johnson, Mylan, Pfizer, Purdue Pharma, Mallinckrodt and Indivior, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oxycodone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oxycodone market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxycodone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxycodone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oxycodone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oxycodone Market by Company

Teva Pharmaceuticals

Sun Pharmaceutical (Chattem Chemicals)

Sanofi

Johnson & Johnson

Mylan

Pfizer

Purdue Pharma

Mallinckrodt

Indivior

Impax Laboratories

Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

Endo International

Oxycodone Segment by Type

Long Acting Oxycodone

Short Acting Oxycodone

Oxycodone Segment by Application

Hospital Pharmacies

Retail Pharmacies

Others

Oxycodone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Long Acting Oxycodone Table 2. Major Company of Short Acting Oxycodone Table 3. Global Oxycodone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oxycodone Sales by Type (2021-2026) & (k units) Table 5. Global Oxycodone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oxycodone Sales Market Share in Value by Type (2021-2026) Table 8. Global Oxycodone Price by Type (2021-2026) & (US$/unit) Table 9. Global Oxycodone Sales by Type (2027-2032) & (k units) Table 10. Global Oxycodone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oxycodone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oxycodone Sales Market Share in Value by Type (2027-2032) Table 13. Global Oxycodone Price by Type (2027-2032) & (US$/unit) Table 14. North America Oxycodone Sales by Type (2021-2026) & (k units) Table 15. North America Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oxycodone Sales by Type (2021-2026) & (k units) Table 17. Europe Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oxycodone Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oxycodone Sales by Type (2021-2026) & (k units) Table 21. Latin America Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oxycodone Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oxycodone Sales by Type (2021-2026) & (US$ Million) Table 24. Oxycodone Industry Trends Table 25. Oxycodone Industry Drivers Table 26. Oxycodone Industry Opportunities and Challenges Table 27. Oxycodone Industry Restraints Table 28. Global Oxycodone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oxycodone Revenue Market Share by Company (2021-2026) Table 30. Global Oxycodone Sales by Company (2021-2026) & (k units) Table 31. Global Oxycodone Sales Share by Company (2021-2026) Table 32. Global Oxycodone Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oxycodone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oxycodone Major Company Production Sites and Headquarters Table 35. Global Oxycodone Company, Product Type & Application Table 36. Global Oxycodone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oxycodone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oxycodone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oxycodone Sales by Region (2021-2026) & (k units) Table 41. Global Oxycodone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oxycodone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oxycodone Sales Market Share in Value by Region (2021-2026) Table 44. Global Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oxycodone Sales by Region (2027-2032) & (k units) Table 46. Global Oxycodone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oxycodone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oxycodone Sales Market Share in Value by Region (2027-2032) Table 49. Global Oxycodone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oxycodone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oxycodone Sales by Application (2021-2026) & (k units) Table 52. Global Oxycodone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oxycodone Sales Market Share in Value by Application (2021-2026) Table 55. Global Oxycodone Price by Application (2021-2026) & (US$/unit) Table 56. Global Oxycodone Sales by Application (2027-2032) & (k units) Table 57. Global Oxycodone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oxycodone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oxycodone Sales Market Share in Value by Application (2027-2032) Table 60. Global Oxycodone Price by Application (2027-2032) & (US$/unit) Table 61. North America Oxycodone Sales by Application (2021-2026) & (k units) Table 62. North America Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oxycodone Sales by Application (2021-2026) & (k units) Table 64. Europe Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oxycodone Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oxycodone Sales by Application (2021-2026) & (k units) Table 68. Latin America Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oxycodone Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oxycodone Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceuticals Company Information Table 72. Teva Pharmaceuticals Business Overview Table 73. Teva Pharmaceuticals Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceuticals Oxycodone Product Portfolio Table 75. Teva Pharmaceuticals Recent Development Table 76. Sun Pharmaceutical (Chattem Chemicals) Company Information Table 77. Sun Pharmaceutical (Chattem Chemicals) Business Overview Table 78. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio Table 80. Sun Pharmaceutical (Chattem Chemicals) Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Oxycodone Product Portfolio Table 85. Sanofi Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Oxycodone Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Mylan Oxycodone Product Portfolio Table 95. Mylan Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Pfizer Oxycodone Product Portfolio Table 100. Pfizer Recent Development Table 101. Purdue Pharma Company Information Table 102. Purdue Pharma Business Overview Table 103. Purdue Pharma Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Purdue Pharma Oxycodone Product Portfolio Table 105. Purdue Pharma Recent Development Table 106. Mallinckrodt Company Information Table 107. Mallinckrodt Business Overview Table 108. Mallinckrodt Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Mallinckrodt Oxycodone Product Portfolio Table 110. Mallinckrodt Recent Development Table 111. Indivior Company Information Table 112. Indivior Business Overview Table 113. Indivior Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Indivior Oxycodone Product Portfolio Table 115. Indivior Recent Development Table 116. Impax Laboratories Company Information Table 117. Impax Laboratories Business Overview Table 118. Impax Laboratories Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Impax Laboratories Oxycodone Product Portfolio Table 120. Impax Laboratories Recent Development Table 121. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information Table 122. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview Table 123. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio Table 125. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development Table 126. Endo International Company Information Table 127. Endo International Business Overview Table 128. Endo International Oxycodone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Endo International Oxycodone Product Portfolio Table 130. Endo International Recent Development Table 131. North America Oxycodone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Oxycodone Sales by Country (2021-2026) & (k units) Table 133. North America Oxycodone Sales Market Share by Country (2021-2026) Table 134. North America Oxycodone Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Oxycodone Sales Market Share Forecast by Country (2027-2032) Table 136. North America Oxycodone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Oxycodone Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Oxycodone Market Share by Country (2021-2026) Table 139. North America Oxycodone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Oxycodone Market Share Forecast by Country (2027-2032) Table 141. Europe Oxycodone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Oxycodone Sales by Country (2021-2026) & (k units) Table 143. Europe Oxycodone Sales Market Share by Country (2021-2026) Table 144. Europe Oxycodone Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Oxycodone Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Oxycodone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Oxycodone Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Oxycodone Market Share by Country (2021-2026) Table 149. Europe Oxycodone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Oxycodone Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Oxycodone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Oxycodone Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Oxycodone Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Oxycodone Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Oxycodone Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Oxycodone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Oxycodone Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Oxycodone Market Share by Country (2021-2026) Table 159. Asia-Pacific Oxycodone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Oxycodone Market Share Forecast by Country (2027-2032) Table 161. Latin America Oxycodone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Oxycodone Sales by Country (2021-2026) & (k units) Table 163. Latin America Oxycodone Sales Market Share by Country (2021-2026) Table 164. Latin America Oxycodone Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Oxycodone Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Oxycodone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Oxycodone Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Oxycodone Market Share by Country (2021-2026) Table 169. Latin America Oxycodone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Oxycodone Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Oxycodone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Oxycodone Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Oxycodone Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Oxycodone Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Oxycodone Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Oxycodone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Oxycodone Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Oxycodone Market Share by Country (2021-2026) Table 179. Middle East and Africa Oxycodone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Oxycodone Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Oxycodone Distributors List Table 184. Oxycodone Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Oxycodone Image Figure 2. Global Oxycodone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Sales (2021-2032) & (k units) Figure 5. Long Acting Oxycodone Image Figure 6. Global Long Acting Oxycodone Sales YoY Growth (2021-2032) & (k units) Figure 7. Short Acting Oxycodone Image Figure 8. Global Short Acting Oxycodone Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oxycodone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oxycodone Market Share by Type 2025 VS 2032 Figure 11. North America Oxycodone Sales Market Share in Volume by Type in 2025 Figure 12. North America Oxycodone Sales Market Share in Value by Type in 2025 Figure 13. Europe Oxycodone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oxycodone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oxycodone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oxycodone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oxycodone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oxycodone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oxycodone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oxycodone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oxycodone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Oxycodone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Oxycodone Market Share by Application 2025 VS 2032 Figure 31. North America Oxycodone Sales Market Share in Volume by Application in 2025 Figure 32. North America Oxycodone Sales Market Share in Value by Application in 2025 Figure 33. Europe Oxycodone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Oxycodone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Oxycodone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Oxycodone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Oxycodone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Oxycodone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Oxycodone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Oxycodone Sales Market Share in Value by Application in 2025 Figure 41. North America Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Oxycodone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Oxycodone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Oxycodone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Oxycodone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Oxycodone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oxycodone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Oxycodone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Oxycodone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Oxycodone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Oxycodone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oxycodone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Oxycodone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oxycodone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Oxycodone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Oxycodone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Oxycodone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Oxycodone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Oxycodone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Oxycodone
  • Short Acting Oxycodone
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Teva Pharmaceuticals
  • Sun Pharmaceutical (Chattem Chemicals)
  • Sanofi
  • Johnson & Johnson
  • Mylan
  • Pfizer
  • Purdue Pharma
  • Mallinckrodt
  • Indivior
  • Impax Laboratories
  • Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oxycodone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oxycodone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oxycodone Market by Type
  6. 1.3.1 Long Acting Oxycodone
  7. 1.3.2 Short Acting Oxycodone
  8. 1.4 Global Oxycodone Market Size by Type
  9. 1.4.1 Global Oxycodone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oxycodone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oxycodone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oxycodone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oxycodone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oxycodone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oxycodone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oxycodone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oxycodone Industry Trends
  2. 2.2 Oxycodone Industry Drivers
  3. 2.3 Oxycodone Industry Opportunities and Challenges
  4. 2.4 Oxycodone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oxycodone Revenue (2021-2026)
  2. 3.2 Global Top Players by Oxycodone Sales (2021-2026)
  3. 3.3 Global Top Players by Oxycodone Price (2021-2026)
  4. 3.4 Global Oxycodone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxycodone Major Company Production Sites & Headquarters
  6. 3.6 Global Oxycodone Company, Product Type & Application
  7. 3.7 Global Oxycodone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxycodone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxycodone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxycodone Tier 1, Tier 2, and Tier 3
4 Oxycodone Regional Status and Outlook
  1. 4.1 Global Oxycodone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oxycodone Historic Market Size by Region
  3. 4.2.1 Global Oxycodone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oxycodone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oxycodone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oxycodone Forecasted Market Size by Region
  7. 4.3.1 Global Oxycodone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oxycodone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oxycodone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oxycodone by Application
  1. 5.1 Oxycodone Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Oxycodone Market Size by Application
  6. 5.2.1 Global Oxycodone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Oxycodone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Oxycodone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Oxycodone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Oxycodone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Oxycodone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Oxycodone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Oxycodone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Oxycodone Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Sun Pharmaceutical (Chattem Chemicals)
  8. 6.2.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
  9. 6.2.2 Sun Pharmaceutical (Chattem Chemicals) Business Overview
  10. 6.2.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
  12. 6.2.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Oxycodone Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Oxycodone Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Oxycodone Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Oxycodone Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Purdue Pharma
  38. 6.7.1 Purdue Pharma Company Information
  39. 6.7.2 Purdue Pharma Business Overview
  40. 6.7.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Purdue Pharma Oxycodone Product Portfolio
  42. 6.7.5 Purdue Pharma Recent Developments
  43. 6.8 Mallinckrodt
  44. 6.8.1 Mallinckrodt Company Information
  45. 6.8.2 Mallinckrodt Business Overview
  46. 6.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mallinckrodt Oxycodone Product Portfolio
  48. 6.8.5 Mallinckrodt Recent Developments
  49. 6.9 Indivior
  50. 6.9.1 Indivior Company Information
  51. 6.9.2 Indivior Business Overview
  52. 6.9.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Indivior Oxycodone Product Portfolio
  54. 6.9.5 Indivior Recent Developments
  55. 6.10 Impax Laboratories
  56. 6.10.1 Impax Laboratories Company Information
  57. 6.10.2 Impax Laboratories Business Overview
  58. 6.10.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Impax Laboratories Oxycodone Product Portfolio
  60. 6.10.5 Impax Laboratories Recent Developments
  61. 6.11 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  62. 6.11.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
  63. 6.11.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
  64. 6.11.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
  66. 6.11.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments
  67. 6.12 Endo International
  68. 6.12.1 Endo International Company Information
  69. 6.12.2 Endo International Business Overview
  70. 6.12.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Endo International Oxycodone Product Portfolio
  72. 6.12.5 Endo International Recent Developments
7 North America by Country
  1. 7.1 North America Oxycodone Sales by Country
  2. 7.1.1 North America Oxycodone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oxycodone Sales by Country (2021-2026)
  4. 7.1.3 North America Oxycodone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oxycodone Market Size by Country
  6. 7.2.1 North America Oxycodone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oxycodone Market Size by Country (2021-2026)
  8. 7.2.3 North America Oxycodone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oxycodone Sales by Country
  2. 8.1.1 Europe Oxycodone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oxycodone Sales by Country (2021-2026)
  4. 8.1.3 Europe Oxycodone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oxycodone Market Size by Country
  6. 8.2.1 Europe Oxycodone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oxycodone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oxycodone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oxycodone Sales by Country
  2. 9.1.1 Asia-Pacific Oxycodone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oxycodone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oxycodone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oxycodone Market Size by Country
  6. 9.2.1 Asia-Pacific Oxycodone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oxycodone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oxycodone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oxycodone Sales by Country
  2. 10.1.1 South America Oxycodone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oxycodone Sales by Country (2021-2026)
  4. 10.1.3 South America Oxycodone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oxycodone Market Size by Country
  6. 10.2.1 South America Oxycodone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oxycodone Market Size by Country (2021-2026)
  8. 10.2.3 South America Oxycodone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oxycodone Sales by Country
  2. 11.1.1 Middle East and Africa Oxycodone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oxycodone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oxycodone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oxycodone Market Size by Country
  6. 11.2.1 Middle East and Africa Oxycodone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oxycodone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oxycodone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oxycodone Value Chain Analysis
  2. 12.1.1 Oxycodone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oxycodone Production Mode & Process
  7. 12.2 Oxycodone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oxycodone Distributors
  10. 12.2.3 Oxycodone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst